Table of Contents
ISRN Medicinal Chemistry
Volume 2013, Article ID 178269, 9 pages
http://dx.doi.org/10.1155/2013/178269
Research Article

New Stability Indicating Method for Quantification of Impurities in Amlodipine and Valsartan Tablets by Validated HPLC

1Quality and Analytical Development Department, InvaGen Pharmaceuticals, Inc., Hauppauge, NY 11788, USA
2Department of Chemistry, Sri Krishnadevaraya University, 515003 Anantapur, India

Received 31 March 2013; Accepted 8 May 2013

Academic Editors: Y. Onuki and U. G. Spizzirri

Copyright © 2013 Rama Joga Venkata Eranki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Budavari, The Merck Index, Merck and Co. Press, Whitehouse Station, NJ, USA, 14th edition, 2006.
  2. http://www.exforge.com/.
  3. The United States Pharmacopoeia Convention, Inc., Rockville, Md, USA, 2007.
  4. A. Zarghi, S. M. Foroutan, A. Shafaati, and A. Khoddam, “Validated HPLC method for determination of amlodipine in human plasma and its application to pharmacokinetic studies,” Farmaco, vol. 60, no. 9, pp. 789–792, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Bahrami and S. H. Mirzaeei, “Simple and rapid HPLC method for determination of AML in human serum with fluorescence detection and its use in pharmacokinetic studies,” Journal of Pharmaceutical and Biomedical Analysis, vol. 36, pp. 163–168, 2004. View at Google Scholar
  6. M. Ahmed, Y. Manohara, and M. Ravi, “RP-HPLC method development and validation for simultaneous estimation of atorvastatin calcium and amlodipine besylate,” International Journal of ChemTech Research, vol. 4, no. 1, pp. 337–345, 2012. View at Google Scholar · View at Scopus
  7. A. P. Agrekar and S. G. Powar, “Reverse phase high performance liquid chromatographic determination of ramipril and AML in tablets,” Journal of Pharmaceutical and Biomedical Analysis, vol. 21, pp. 1137–1142, 2000. View at Google Scholar
  8. B. G. Chaudhari, N. M. Patel, and P. B. Shah, “Stability indicating RP-HPLC method for simultaneous determination of atorvastatin and amlodipine from their combination drug products,” Chemical and Pharmaceutical Bulletin, vol. 55, no. 2, pp. 241–246, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. K. K. Pandya, M. Satia, T. P. Gandhi, I. A. Modi, R. I. Modi, and B. K. Chakravarthy, “Detection and determination of total amlodipine by high-performance thin-layer chromatography: a useful technique for pharmacokinetic studies,” Journal of Chromatography B, vol. 667, no. 2, pp. 315–320, 1995. View at Publisher · View at Google Scholar · View at Scopus
  10. S. N. Meyyanathan and B. Suresh, “HPTLC method for the simultaneous determination of amlodipine and benazepril in their formulations,” Journal of Chromatographic Science, vol. 43, no. 2, pp. 73–75, 2005. View at Google Scholar · View at Scopus
  11. Y. Feng, L. Zhang, Z. Shen, F. Pan, and Z. Zhang, “Analysis of amlodipine in human plasma by liquid chromatography-mass spectrometry,” Journal of Chromatographic Science, vol. 40, no. 1, pp. 49–53, 2002. View at Google Scholar · View at Scopus
  12. J. Bhatt, S. Singh, G. Subbaiah, B. Shah, S. Kambli, and S. Ameta, “A rapid and sensitive liquid chromatography-tandem mass spectrometry (LS-MS/MS) method for the estimation of amlodipine in human plasma,” Biomedical Chromatography, vol. 21, no. 2, pp. 169–175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. D. Malesuik, S. G. Cardoso, L. Baierski, and F. A. Lanzanova, “Determination of amlodipine in pharmaceutical dosage forms by liquid chromatograpy and ultraviolet spectrophotometry,” Journal of AOAC International, vol. 89, no. 2, pp. 359–364, 2006. View at Google Scholar · View at Scopus
  14. R. Sahu and V. B. Patel, “Simultaneous spectrophotometric determination of amlodipine besylate and atorvastatin calcium in binary mixture,” Indian Journal of Pharmaceutical Sciences, vol. 69, no. 1, pp. 110–111, 2007. View at Google Scholar · View at Scopus
  15. B. Koçyigit-Kaymakcoglu, S. Ünsalan, and S. Rollas, “Determination and validation of ketoprofen, pantoprazole and valsartan together in human plasma by high performance liquid chromatography,” Pharmazie, vol. 61, no. 7, pp. 586–589, 2006. View at Google Scholar · View at Scopus
  16. N. Daneshtalab, R. Z. Lewanczuk, and F. Jamali, “High-performance liquid chromatographic analysis of angiotensin II receptor antagonist valsartan using a liquid extraction method,” Journal of Chromatography B, vol. 766, no. 2, pp. 345–349, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. L. González, J. A. López, R. M. Alonso, and R. M. Jiménez, “Fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection,” Journal of Chromatography A, vol. 949, no. 1-2, pp. 49–60, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Koseki, H. Kawashita, H. Hara et al., “Development and validation of a method for quantitative determination of valsartan in human plasma by liquid chromatography-tandem mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 43, no. 5, pp. 1769–1774, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Li, Y. Wang, Y. Jiang et al., “A liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of valsartan and hydrochlorothiazide in human plasma,” Journal of Chromatography B, vol. 852, no. 1-2, pp. 436–442, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. P. S. Selvan, K. V. Gowda, U. Mandal, W. D. S. Solomon, and T. K. Pal, “Simultaneous determination of fixed dose combination of nebivolol and valsartan in human plasma by liquid chromatographic-tandem mass spectrometry and its application to pharmacokinetic study,” Journal of Chromatography B, vol. 858, no. 1-2, pp. 143–150, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Macek, J. Klíma, and P. Ptáček, “Rapid determination of valsartan in human plasma by protein precipitation and high-performance liquid chromatography,” Journal of Chromatography B, vol. 832, no. 1, pp. 169–172, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Hillaert and W. Van Den Bossche, “Simultaneous determination of hydrochlorothiazide and several angiotensin-II-receptor antagonists by capillary electrophoresis,” Journal of Pharmaceutical and Biomedical Analysis, vol. 31, no. 2, pp. 329–339, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Satana, S. Altinay, N. G. Goger, S. A. Ozkan, and Z. J. Senturk, “Simultaneous determination of VAL and Hydrochlorothiazide in tablets by first-derivative ultraviolet spectrophotometry and LC,” Journal of Pharmaceutical and Biomedical Analysis, vol. 25, pp. 1009–1013, 2001. View at Google Scholar
  24. S. Tatar and S. Salk, “Comparison of UV- and second derivative-spectrophotometric and LC methods for the determination of valsartan in pharmaceutical formulation,” Journal of Pharmaceutical and Biomedical Analysis, vol. 30, no. 2, pp. 371–375, 2002. View at Publisher · View at Google Scholar · View at Scopus